Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
US8575099B2 · kind B2 · utility
2Cited by
14References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 30, 2007 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Apr 25, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4753
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses an agent for treating a polyglutamine aggregation-caused disease or suppressing its onset, which comprises, as an active ingredient, (1) (i) HGF protein, (ii) a partial peptide of HGF protein that is substantially equivalent in activity to HGF protein, or a salt of either of them, or
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.